Skip to main content
. 2021 Mar 27;25(10):5823–5831. doi: 10.1007/s00784-021-03887-8

Table 3.

Expression of the mRNA of the isoforms in CAFs, divided into different tumor stages T1 to T4

Comparison between expression of Cav-1α in CAFs of different tumor stages
T1 (n = 3) T2 (n = 6) T3 (n = 2) T4 (n = 8) p
Cav-1α

Median

(Q1; Q3)

0.29

(0.19; 0.65)

0.62

(0.18; 1.37)

0.65

(0.46; 0.83)

1.37

(0.93; 2.00)

p = 0.007
Pairwise comparison of Cav-1α in different tumor stages
T1 - T3 T1 - T2 T1 - T4 T3 - T2 T3 - T4 T2 - T4
Cav-1α p = 0.604 p = 0.379 p = 0.008 p = 0.856 p = 0.092 p = 0.028
Comparison between expression of Cav-1β in CAFs of different tumor stages
T1 (n = 3) T2 (n = 6) T3 (n = 2) T4 (n = 8) p
Cav-1β

Median

(Q1; Q3)

3.84

(1.56; 5.75)

1.54

(0.79; 2.18)

3.99

(3.03; 4.94)

3.01

(2.11; 4.20)

p = 0.041
Pairwise comparison Cav-1β in different tumor stages
T1 - T3 T1 - T2 T1 - T4 T3 - T2 T3 - T4 T2 - T4
Cav-1β p = 1.00 p = 0.167 p = 0.776 p = 0.071 p = 0.533 p = 0.020
Comparison between expression of Cav-1α and Cav-1β in CAFs of tumor stages T4 (n = 8)
Cav-1α Cav-1β p

Median

(Q1; Q3)

1.37

(0.93; 2.00)

3.01

(2.11; 4.20)

p = 0.016